Solventum (NYSE: SOLV) director converts 3,403 RSUs into common stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Solventum Corp director Mily Elizabeth exercised restricted stock units into common shares. On April 30, 2026, 3,403 Restricted Stock Units were converted into 3,403 shares of Solventum common stock at a stated price of $0.00 per share, reflecting a compensation-related equity settlement rather than a market purchase.
Following this exercise, Elizabeth directly held 9,009 shares of Solventum common stock. The RSUs referenced were fully vested and each RSU represented a contingent right to receive one share of common stock upon settlement. The filing shows no open-market sales or tax-withholding dispositions linked to this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,403 shares exercised/converted
Mixed
2 txns
Insider
Mily Elizabeth
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,403 | $0.00 | -- |
| Exercise | Common Stock | 3,403 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct, null);
Common Stock — 9,009 shares (Direct, null)
Footnotes (1)
- Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. The RSUs are fully vested.
Key Figures
RSUs exercised: 3,403 units
Common shares acquired: 3,403 shares
Shares held after transaction: 9,009 shares
+2 more
5 metrics
RSUs exercised
3,403 units
Restricted Stock Units converted to common stock on April 30, 2026
Common shares acquired
3,403 shares
Common Stock received from RSU settlement
Shares held after transaction
9,009 shares
Direct ownership following April 30, 2026 exercise
Exercise price
$0.00 per share
Recorded transaction and conversion price for RSUs
Derivative expiration date
April 30, 2035
Expiration date associated with the RSU award
Key Terms
Restricted Stock Units, derivative security, contingent right, fully vested
4 terms
Restricted Stock Units financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"represents a contingent right to receive 1 share of the issuer's Common Stock"
fully vested financial
"The RSUs are fully vested."
FAQ
What did Solventum (SOLV) director Mily Elizabeth report in this Form 4 filing?
Mily Elizabeth reported exercising 3,403 Restricted Stock Units into 3,403 shares of Solventum common stock. The RSUs were fully vested, and the transaction reflects equity compensation settlement rather than an open-market stock purchase or sale.
What are Restricted Stock Units (RSUs) in the context of Solventum (SOLV)?
In this filing, each Restricted Stock Unit represents a contingent right to receive one share of Solventum common stock upon settlement. The RSUs reported were fully vested, meaning the director had satisfied required conditions to receive the underlying shares.
Did Solventum (SOLV) director Mily Elizabeth retain derivative positions after this transaction?
The filing shows 3,403 Restricted Stock Units exercised into common stock, with zero RSUs remaining in that specific award. The derivative summary section is empty, indicating no additional derivative positions are visible in this particular Form 4 excerpt.
What was the exercise price for the Solventum (SOLV) RSUs in this Form 4?
The RSU exercise is recorded with a transaction and conversion price of $0.00 per share. This is typical for RSUs, which generally convert into common stock without a cash payment when vesting and settlement conditions are met by the reporting person.